醫療仿生學市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測,按類型、按應用、按公司和按地區分類
市場調查報告書
商品編碼
1289652

醫療仿生學市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測,按類型、按應用、按公司和按地區分類

Medical Biomimetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Application, By company and By Region

出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2023-2027年的預測期內,全球醫學仿生學市場預計將出現令人矚目的成長。主要因素包括慢性病的發生率不斷增加,醫療仿生學的應用不斷增加,以及技術的廣泛發展,這些都遏制了市場的成長。生物仿生學是一個跨學科領域,包括生物學、工程學和化學。它被用於開發生物相容性材料,使醫療保健專家能夠監測和治療慢性疾病。它被用於再生醫學、組織工程和藥物輸送。支持市場成長的其他因素有:研發活動的增加,政府資金的增加,器官衰竭發病率的增加,發達和發展中經濟體醫療保健支出的增加,人口老齡化的增加,合併和戰略收購的數量增加,預期壽命的增加,以及對假體和植入物需求的增加。

慢性疾病發病率的增加

慢性疾病,如心血管疾病、糖尿病和其他疾病的發生率越來越高,促進了全球市場的成長。由於久坐的生活方式和不健康的飲食選擇,人們正在遭受這些疾病的困擾,這推動了市場的成長。例如,根據美國疾病控制和預防中心(CDC)的數據,大約每40秒就有一個美國人死於心臟病發作。據估計,每年有80.5萬美國人心臟病發作,其中60.5萬是第一次發作。老年人口極易患上骨科疾病、心血管疾病以及神經系統疾病等疾病。因此,增加了醫療生物仿生學市場的成長。根據國家腎臟基金會的數據,在全球範圍內,65至74歲的人中有四分之一的女性和五分之一的男性患有慢性腎臟疾病。

生物仿生技術的進步

醫療保健領域的快速進步,如機器人技術、3D列印技術和其他技術,正在推動市場的成長。在奈米技術、組織工程和其他領域擴大採用各種創新,預計將創造許多機會,抑制市場成長。採用奈米技術可以幫助發展個性化醫療、器官再生、整形手術和藥物輸送。例如,在美國,2020年,Veryan Medical公司推出了一種新穎的BioMimics 3D血管支架系統。 BioMimics是一個以在臨床試驗中取得超卓成果為目標的系統。

生物仿生學的應用越來越多

醫療領域對生物仿生學的需求不斷成長,推動了市場的成長。這要歸功於在牙科、心臟病學、骨科、眼科等各個領域的應用不斷增加。生物仿生學被用於治療各種疾病,如阿滋海默症、假肢、器官移植等。此外,醫療行業中無創程序(包括心電圖、CT掃描和超音波)中的醫用生物仿生技術的應用激增,預計將抑制市場的成長。例如,根據美國政府的數據,在2017年,全國大約進行了34,770例移植手術。

可用的定製服務

利用給定的市場數據,TechSci Research根據公司的具體需求提供定製服務。該報告可提供以下定製選項:

公司資訊

  • 對其他市場參與者(最多5家)的詳細分析和簡介。

目錄

第一章:產品概述

第二章:研究方法

第三章:執行摘要

第四章:COVID-19對全球醫用生物仿生學市場的影響

第五章:客戶的聲音

第六章:全球醫用仿生學市場展望

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型(心血管、骨科、眼科、牙科、其他)分類
    • 按應用(傷口癒合、組織工程、藥物輸送、整形外科、其他)分類
    • 按地區分類
    • 按公司分類(2021年)
  • 市場地圖

第七章:北美醫用生物仿生學市場展望

  • 市場規模和預測
    • 按價值分類
  • 市場佔有率與預測
    • 按類型
    • 按應用分類
    • 按國家分類
  • 北美洲:國家分析
    • 美國
    • 美國
    • 墨西哥

第8章:歐洲醫用仿生學市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型
    • 按應用分類
    • 按國家分類
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第九章:亞太醫療仿生學市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型
    • 按應用分類
    • 按國家分類
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第十章:南美醫療仿生學市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型
    • 按應用分類
    • 按國家分類
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章:中東和非洲醫療仿生學市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率和預測
    • 按類型
    • 按應用分類
    • 按國家分類
  • MEA: 國家分析
    • 南非醫學仿生學
    • 沙烏地阿拉伯醫學生物仿生學
    • 阿拉伯聯合大公國醫學仿生學
    • 土耳其醫學仿生學
    • 埃及醫學仿生學

第十二章:市場動態

  • 驅動力
  • 挑戰

第十三章:市場趨勢與發展

第十四章:競爭格局

  • Wright Medical Group NV Abbott Laboratories, Inc.Blatchford Group (Chas. A. Blatchford & Sons Ltd) BioHorizons IPH, Inc.Biomimetics Technology Inc SynTouch Inc.Vandstrom, Inc.Gelesis, Inc.BioTomo Pty.Ltd.)。 Hstar技術公司

第十五章:戰略建議

簡介目錄
Product Code: 13008

The global medical biomimetics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing occurrences of chronic diseases, increasing applications of medical biomimetics, and extensive development in technology that are curbing the growth of the market. Biomimetics is an interdisciplinary field that comprises biology, engineering, and chemistry. It is used for the development of biocompatible material, which allows healthcare experts to monitor and treat chronic diseases. It is used for regenerative medicine, tissue engineering, and drug delivery. The other factors supporting the market's growth are, rise in R&D activities, increasing favorable government funding, growing incidences of organ failure, the rising healthcare expenditure in developed and developing economies, rise in aging population base, growing number of mergers and strategic acquisitions, growing life expectancy, and rise in demand for prosthesis and implants.

Increasing Prevalence of Chronic Diseases

The growing occurrences of chronic diseases, such as cardiovascular diseases, diabetes, and others, are bolstering the growth of the market globally. Owing to the sedentary lifestyle and unhealthy eating choices, people are suffering from these diseases, which propels the growth of the market. For instance, as per the Centers for Disease Control and Prevention (CDC), roughly every 40 seconds, an American die from a heart attack. It is estimated that 805,000 Americans have a heart attack every year, 605,000 of them for the first time. Geriatric populations are highly prone to diseases such as orthopedic diseases, cardiovascular diseases as well as neurological disorders. Thus, increasing the growth of the medical biomimetics market. According to the National Kidney Foundation, one in four women and one in five men aged between 65 to 74 years have chronic kidney disease across the globe.

Advancements in Biomimetic Technologies

Rapid advancements such as robotics, 3D printing technology, and others in the healthcare sector are surging the growth of the market. The increasing adoption of various innovations in areas of nanotechnology, tissue engineering, and others is expected to create numerous opportunities which curb the market growth. The adoption of nanotechnology can aid in the development of personalized medicine, organ regeneration, plastic surgery, and drug delivery. For instance, in the U.S., in 2020, Veryan Medical launched a novel BioMimics 3D vascular stent system. BioMimics is a system that aims for superb outcomes in clinical trials.

Increasing Applications of Biomimetics

The growing demand for biomimetics in the medical sector is fueling the growth of the market. This is attributed to the increasing application in various fields such as dentistry, cardiology, orthopedics, ophthalmology, and others. Biomimetics is used for the treatment of various diseases, such as Alzheimer, prosthetics, organ transplants, and others. Moreover, an upsurge in the application of medical biomimetics in noninvasive procedures, including ECGs, CT scans, and ultrasound, in the healthcare industry is anticipated to curb the growth in the market. For instance, as per the U.S. government's data, in 2017, approximately 34,770 transplants were conducted in the nation.

Market Segmentation

The global medical biomimetics market is segmented into type, application, and company. Based on type, the market is divided into cardiovascular, orthopedic, ophthalmology, dental, and others. Based on application, the market is divided into wound healing, tissue engineering, drug delivery, plastic surgery, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in the adoption rate of novel technology in the country.

Market Players

Wright Medical Group N.V., Abbott Laboratories, Inc., Blatchford Group (Chas. A. Blatchford & Sons Ltd), BioHorizons IPH, Inc., Biomimetics Technology Inc, SynTouch Inc., Vandstrom, Inc., Gelesis, Inc., BioTomo Pty. Ltd., and Hstar Technologies Corporation are some of the leading companies operating in the market.

Report Scope

In this report, global medical biomimetics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Biomimetics Market, By Type:

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Others

Medical Biomimetics Market, By Application:

  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Plastic Surgery
  • Others

Medical Biomimetics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Medical Biomimetics Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Medical Biomimetics Market

5. Voice of Customer

6. Global Medical Biomimetics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Cardiovascular, Orthopedic, Ophthalmology, Dental, Others)
    • 6.2.2. By Application (Wound Healing, Tissue Engineering, Drug Delivery, Plastic Surgery, Others)
    • 6.2.3. By Region
    • 6.2.4. By Company (2021)
  • 6.3. Market Map

7. North America Medical Biomimetics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Medical Biomimetics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Canada Medical Biomimetics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Mexico Medical Biomimetics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application

8. Europe Medical Biomimetics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Medical Biomimetics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. Germany Medical Biomimetics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. United Kingdom Medical Biomimetics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Italy Medical Biomimetics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Spain Medical Biomimetics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Asia-Pacific Medical Biomimetics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Medical Biomimetics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. India Medical Biomimetics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Japan Medical Biomimetics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
    • 9.3.4. South Korea Medical Biomimetics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
    • 9.3.5. Australia Medical Biomimetics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application

10. South America Medical Biomimetics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Medical Biomimetics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Argentina Medical Biomimetics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Colombia Medical Biomimetics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Middle East and Africa Medical Biomimetics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Application
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Medical Biomimetics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
    • 11.3.2. Saudi Arabia Medical Biomimetics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
    • 11.3.3. UAE Medical Biomimetics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
    • 11.3.4. Turkey Medical Biomimetics Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type
        • 11.3.4.2.2. By Application
    • 11.3.5. Egypt Medical Biomimetics Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Type
        • 11.3.5.2.2. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Wright Medical Group N.V.
  • 14.2. Abbott Laboratories, Inc.
  • 14.3. Blatchford Group (Chas. A. Blatchford & Sons Ltd)
  • 14.4. BioHorizons IPH, Inc.
  • 14.5. Biomimetics Technology Inc
  • 14.6. SynTouch Inc.
  • 14.7. Vandstrom, Inc.
  • 14.8. Gelesis, Inc.
  • 14.9. BioTomo Pty. Ltd.
  • 14.10. Hstar Technologies Corporation

15. Strategic Recommendations